On the ADC front, ABL has partnered with LegoChem Biosciences (141080 under the Korean Securities ... targeting a novel RMT receptor on brain endothelial cells. The result is ABL301, a first ...
This is maintained by the blood–brain barrier, whereby specialized brain endothelial cells lining the inner walls of blood vessels regulate the exchange of molecules between the circulatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback